Pathogenesis of hypertriglyceridemia: implications for coronary heart disease and therapy.
Vega
G L
GL
University of Texas Southwestern Medical Center, Dallas 75235-9052.
Grundy
S M
SM
D001692:Biological Transport; D003327:Coronary Disease / Q000209:etiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D015228:Hypertriglyceridemia / Q000150:complications / Q000209:etiology* / Q000628:therapy; D008066:Lipolysis; D008074:Lipoproteins / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008074:Lipoproteins; D008079:Lipoproteins, VLDL; D014280:Triglycerides; C030106:very low density lipoprotein triglyceride